About this trial
Benign prostatic hyperplasia (BPH) is a common condition in older men and may cause bothersome lower urinary tract symptoms that can negatively affect quality of life. Surgical treatment with Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) is often recommended when medical therapy is insufficient.
This prospective observational study aims to evaluate whether preoperative anxiety, depression, and surgical fear influence postoperative functional outcomes, urinary continence, erectile function, and patient satisfaction in patients undergoing HoLEP or TURP for BPH. Participants will complete validated psychological and functional questionnaires before surgery and during postoperative follow-up visits at 1 and 3 months. The study will also assess changes in psychological status after surgery and compare outcomes between HoLEP and TURP patients.
The findings may help improve preoperative patient counseling and identify patients who could benefit from additional psychological support before surgery.
Eligibility criteria
Qualifiers
Male patients aged 50 years or older
Diagnosis of benign prostatic hyperplasia (BPH)
Scheduled to undergo HoLEP or TURP
Ability to understand and complete study questionnaires
Disqualifiers
History of severe psychiatric disorder
Active psychiatric treatment
Neurogenic bladder or neurologic voiding dysfunction
Diagnosis of prostate cancer
Trial design
Treatments tested in this trial
- Holmium Laser Enucleation of the Prostate (HoLEP)
- Transurethral Resection of the Prostate (TURP)